SLNSW-Phase 2 study of lenvatinib monotherapy as second...-TN_cdi_doaj_primary_oai_doaj_org_article_8403f3bcb9b14a4587ff1a87da4dbffb

Phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: primary analysis results

Full title: Phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: primary analysis results

Author/creator: Ueno, Makoto, Ikeda, Masafumi, Sasaki, Takashi, Nagashima, Fumio, Mizuno, Nobumasa, Shimizu, Satoshi, Ikezawa, Hiroki, Hayata, Nozomi, Nakajima, Ryo, Morizane, Chigusa.

Call Numbers:

Record Identifier: TN_cdi_doaj_primary_oai_doaj_org_article_8403f3bcb9b14a4587ff1a87da4dbffb

Language: English

Formats: Articles

Publishers: England: BioMed Central Ltd

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8403f3bcb9b14a4587ff1a87da4dbffb

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    Phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: primary analysis results

    Record identifier

    TN_cdi_doaj_primary_oai_doaj_org_article_8403f3bcb9b14a4587ff1a87da4dbffb

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8403f3bcb9b14a4587ff1a87da4dbffb

    Share

    Phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: primary analysis results

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8403f3bcb9b14a4587ff1a87da4dbffb

    Phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: primary analysis results

    Full title

    Phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: primary analysis results

    Author / Creator

    Ueno, Makoto ; Ikeda, Masafumi ; Sasaki, Takashi ; Nagashima, Fumio ; Mizuno, Nobumasa ; Shimizu, Satoshi ; Ikezawa, Hiroki ; Hayata, Nozomi ; Nakajima, Ryo ; Morizane, Chigusa

    Publisher

    England: BioMed Central Ltd

    Journal title

    BMC cancer, 2020, Vol.20 (1), p.1105-1105

    Record Identifier

    TN_cdi_doaj_primary_oai_doaj_org_article_8403f3bcb9b14a4587ff1a87da4dbffb

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    Adult Aged Ampulla of Vater Antineoplastic Agents - therapeutic use Antitumor activity Appetite Biliary tract Biliary tract cancer Biliary Tract Neoplasms - drug therapy Biliary Tract Neoplasms - pathology Blood pressure Cancer Cancer therapies Cholangiocarcinoma Consent Disease control Drug dosages Female Fibroblast growth factor Fibroblast growth factor receptors Follow-Up Studies Gallbladder Gallbladder cancer Humans Hypertension Lenvatinib Male Medical prognosis Metastasis Middle Aged Oncology, Experimental Patients Pharmacokinetics Phenylurea Compounds - therapeutic use Plasma Platelet-derived growth factor Prognosis Proteinuria Quinolines - therapeutic use Salvage Therapy Survival Survival Rate Thrombocytopenia Vascular endothelial growth factor

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_doaj_primary_oai_doaj_org_article_8403f3bcb9b14a4587ff1a87da4dbffb

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8403f3bcb9b14a4587ff1a87da4dbffb

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    View in old catalogue

    Connecting people and collections